Review Article

Sexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management

Table 2

Clinical management studies.

StudyPopulationMethodResults

Wasserman et al., 2008 [66]3 HIV+ male with ED, decreased morning erections, and libido, wasting syndrome, and hypogonadismCase report.
All presented low testosterone and SHBG serum levels while using oxandrolone and testosterone
After discontinuing oxandrolone one showed improved libido and ED and all showed improved testosterone and SHBG

Richardson et al., 2007 [70]13 MSM HIV+ on HAART with LSD and estradiol levels >120 pmol/LSubjects were randomly allocated to receive testosterone ( 𝑁 = 6 ) or letrozole ( 𝑁 = 7 ) for 6 weeks.
Spector Sexual Desire Inventory (SSDI), Depression/Anxiety Stress Scale (DASS) were used
Desire and mean sexual acts improved in both treatment arms.
Luteinizing hormone and testosterone increased in all men on letrozole

Schrader et al., 2005 [42]48 HIV+ males with decreased testosterone levels, libido, and sexual functioningMulticenter randomized controlled trial. Testim gel was used by 24 men after 2 weeks using AndroGel. Brief male sexual function inventory (BMSFI) was usedExperimental group improved in 4 of 5 domains (sexual drive, erectile function, problem assessment, and sexual satisfaction) of BMSFI ( 𝑃 < 0 . 0 5 )

Catalan and Meadows, 2000 [27]34 gay and bisexual men HIV+Cross-sectional study.
Nonstandardized instrument was used
Cognitive behavioral therapy, alprostadil, and sildenafil.76% resolved the problem and 14% improved, particularly with physical therapy

Rabkin et al., 2000 [69]74 HIV+ male outpatientsDouble-blind, placebo-controlled 6-week trial with biweekly testosterone injections, followed by 12 weeks.
Clinical Global Impressions Scale (CGIS) was used
Testosterone group improved more on libido and energy than placebo group ( 𝑃 < 0 . 0 5 ). Parameters were kept by 18 weeks

Wagner and Rabkin, 1998 [45]23 AIDS eugonadal men with hypogonadism symptomsIntervention study of 12 weeks of biweekly intramuscular injections of testosterone cypionate CGIS was usedMajority of the 19 subjects who completed the trial showed improvement of SD and other hypogonadism symptoms

Note: AndroGel is a registered trademark of Solvay Pharmaceuticals, Inc., Marietta, Georgia, USA, and Testim is a registered trademark of Auxilium Pharmaceuticals, Inc., Norristown, Pennsylvania, USA. MSM: Men who have sex with men. SD: sexual dysfunctions.